Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10166191 Sustained-release dosage forms of ruxolitinib

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 28 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 28 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12071439 Process and intermediates for preparing a JAK inhibitor
0
Edits on 17 Apr, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 17 Apr, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11957661 JAK1 pathway inhibitors for the treatment of vitiligo
0
Edits on 22 Feb, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 22 Feb, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11905292 Process and intermediates for preparing a JAK inhibitor
0
Edits on 8 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 8 Dec, 2023
Edits made to:
Article (+266 characters)
Article

Patent abstract

The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.

Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11833155 Combination therapy for treatment of myeloproliferative neoplasms
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11833152 JAK1 pathway inhibitors for the treatment of cytokine-related disorders
0
Edits on 7 Sep, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Sep, 2023
Edits on 27 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Apr, 2023
Edits on 24 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2023
Edits on 24 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Incyte
Incyte
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
101661910
Date of Patent
January 1, 2019
0
Patent Application Number
140799010
Date Filed
November 14, 2013
0
Patent Citations Received
‌
US Patent 10874616 Sustained-release dosage forms of ruxolitinib
0
‌
US Patent 11045421 Sustained release dosage forms for a JAK1 inhibitor
0
‌
US Patent 11285140 Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
0
‌
US Patent 11331320 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
0
‌
US Patent 11324749 Combination therapy for treatment of hematological diseases
0
‌
US Patent 11337927 Sustained-release dosage forms of ruxolitinib
0
‌
US Patent 11372003 Biomarkers for graft-versus-host disease
0
‌
US Patent 11510923 Ruxolitinib formulation for reduction of itch in atopic dermatitis
0
‌
US Patent 11576864 Sustained-release dosage forms of ruxolitinib
0
‌
US Patent 11576865 Sustained-release dosage forms of ruxolitinib
0
‌
US Patent 11584961 Biomarkers for inflammatory skin disease
0
Patent Primary Examiner
‌
Umamaheswari Ramachandran
0
Edits on 3 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 3 Apr, 2023
Edits on 28 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Mar, 2023
Edits on 28 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Mar, 2023
Edits on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
Edits on 22 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Mar, 2023
Edits on 23 Feb, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 23 Feb, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11584961 Biomarkers for inflammatory skin disease
0
Edits on 15 Feb, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 15 Feb, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11576865 Sustained-release dosage forms of ruxolitinib
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 15 Feb, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11576864 Sustained-release dosage forms of ruxolitinib
0
Edits on 30 Nov, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Nov, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11510923 Ruxolitinib formulation for reduction of itch in atopic dermatitis
0

Find more entities like US Patent 10166191 Sustained-release dosage forms of ruxolitinib

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.